• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通外科手术后静脉血栓栓塞的预防。预防性替代方法的成本效益分析。

Prevention of venous thromboembolism after general surgery. Cost-effectiveness analysis of alternative approaches to prophylaxis.

作者信息

Oster G, Tuden R L, Colditz G A

出版信息

Am J Med. 1987 May;82(5):889-99. doi: 10.1016/0002-9343(87)90149-5.

DOI:10.1016/0002-9343(87)90149-5
PMID:3107384
Abstract

A number of methods of prophylaxis can reduce the risk of postoperative venous thromboembolism in patients undergoing general surgery. The cost-effectiveness of several of these--low-dose subcutaneous heparin, intermittent pneumatic compression, graduated compression stockings, heparin plus dihydroergotamine, heparin plus stockings, and intermittent pneumatic compression plus stockings--was assessed by pooling data from published reports of randomized controlled trials. Using clinical protocols, costs for prophylaxis, diagnosis, and treatment of venous thromboembolism were determined. The expected outcomes and costs of each strategy were then calculated using techniques of decision analysis. The results indicate that stockings are the only prophylactic method that is actually cost-saving. Costs of care average $34 less per admission for patients using stockings than for those receiving no prophylaxis. Most other methods of prophylaxis further reduce thromboembolic risk, but increase costs by $50 to $88 per patient relative to costs for the use of stockings. Differences in the cost-effectiveness of these prophylaxis are more marked, ranging from about $50,000 to almost $500,000 per additional life saved.

摘要

多种预防方法可降低普通外科手术患者术后静脉血栓栓塞的风险。通过汇总随机对照试验已发表报告中的数据,评估了其中几种方法——小剂量皮下注射肝素、间歇性充气加压、分级加压弹力袜、肝素加双氢麦角胺、肝素加弹力袜以及间歇性充气加压加弹力袜——的成本效益。采用临床方案确定静脉血栓栓塞的预防、诊断和治疗成本。然后使用决策分析技术计算每种策略的预期结果和成本。结果表明,弹力袜是唯一实际节省成本的预防方法。使用弹力袜的患者每次住院护理费用平均比未接受任何预防措施的患者少34美元。大多数其他预防方法进一步降低了血栓栓塞风险,但相对于使用弹力袜的成本,每位患者的成本增加了50至88美元。这些预防措施在成本效益方面的差异更为显著,每多挽救一条生命的成本从约5万美元到近50万美元不等。

相似文献

1
Prevention of venous thromboembolism after general surgery. Cost-effectiveness analysis of alternative approaches to prophylaxis.普通外科手术后静脉血栓栓塞的预防。预防性替代方法的成本效益分析。
Am J Med. 1987 May;82(5):889-99. doi: 10.1016/0002-9343(87)90149-5.
2
A prospective comparison of thromboembolic stockings, external sequential pneumatic compression stockings and heparin sodium/dihydroergotamine mesylate for the prevention of thromboembolic complications in urological surgery.前瞻性比较血栓栓塞性弹力袜、外部序贯气压式压迫弹力袜与肝素钠/甲磺酸双氢麦角胺预防泌尿外科手术中血栓栓塞并发症的效果。
J Urol. 1991 Jun;145(6):1205-8. doi: 10.1016/s0022-5347(17)38576-2.
3
A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery.大型骨科手术中预防深静脉血栓形成的成本效益分析
JAMA. 1987 Jan 9;257(2):203-8.
4
Prophylaxis of deep vein thrombosis after major abdominal surgery. Comparison between dihydroergotamine-heparin and intermittent pneumatic calf compression and evaluation of added graduated static compression.腹部大手术后深静脉血栓形成的预防。双氢麦角胺-肝素与间歇性小腿充气加压的比较及附加分级静态加压的评估
Acta Chir Scand. 1986 Oct;152:597-600.
5
Rates of venous thrombosis after general surgery: combined results of randomised clinical trials.普通外科手术后静脉血栓形成的发生率:随机临床试验的综合结果。
Lancet. 1986 Jul 19;2(8499):143-6. doi: 10.1016/s0140-6736(86)91955-0.
6
Regimen for improved effectiveness of intermittent pneumatic compression in deep venous thrombosis prophylaxis.
Surgery. 1987 Nov;102(5):816-20.
7
Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery.间歇性气动压迫在普外科预防静脉血栓栓塞中的成本效益
Int Angiol. 2008 Dec;27(6):500-6.
8
Intermittent sequential pneumatic compression of the legs and thromboembolism-deterrent stockings in the prevention of postoperative deep venous thrombosis.
Surgery. 1983 Jul;94(1):21-5.
9
Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.依诺肝素联合弹力袜与单纯弹力袜预防择期神经外科手术后静脉血栓栓塞的比较。
N Engl J Med. 1998 Jul 9;339(2):80-5. doi: 10.1056/NEJM199807093390204.
10
Low dose heparin and compression stockings in the prevention of postoperative deep venous thrombosis.
Br J Surg. 1980 Jul;67(7):482-4. doi: 10.1002/bjs.1800670710.

引用本文的文献

1
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.美国血液学会 2021 年静脉血栓栓塞症管理指南:癌症患者的预防和治疗。
Blood Adv. 2021 Feb 23;5(4):927-974. doi: 10.1182/bloodadvances.2020003442.
2
Venous thromboembolism in Pakistan: a neglected research agenda.巴基斯坦的静脉血栓栓塞症:被忽视的研究议程。
J Thromb Thrombolysis. 2013 Feb;35(2):234-42. doi: 10.1007/s11239-012-0799-2.
3
Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
非骨科手术患者静脉血栓栓塞症的预防:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e227S-e277S. doi: 10.1378/chest.11-2297.
4
Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery.与低分子量肝素相比,磺达肝癸钠延长预防对髋部骨折手术患者静脉血栓栓塞的成本效益。
Eur J Health Econ. 2007 Dec;8(4):313-23. doi: 10.1007/s10198-006-0017-2. Epub 2007 Jan 16.
5
Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.依诺肝素预防急性病内科住院患者静脉血栓栓塞并发症的成本效益:德国医院视角的建模研究
Pharmacoeconomics. 2006;24(6):571-91. doi: 10.2165/00019053-200624060-00005.
6
Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients.依诺肝素预防急性内科疾病患者静脉血栓栓塞的经济学评价
Pharm World Sci. 2004 Aug;26(4):214-20. doi: 10.1023/b:phar.0000035887.23072.e5.
7
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.测量大型骨科手术中静脉血栓栓塞预防的结果及药物经济学后果。
Pharmacoeconomics. 2003;21(7):477-96. doi: 10.2165/00019053-200321070-00003.
8
Cost effectiveness of desirudin compared with a low molecular weight heparin in the prevention of deep vein thrombosis after total hip replacement surgery.与低分子量肝素相比,地西卢定在预防全髋关节置换术后深静脉血栓形成方面的成本效益。
Pharmacoeconomics. 2001;19(5 Pt 2):589-97. doi: 10.2165/00019053-200119050-00012.
9
Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.机构处方集:药物经济学分析与处方集决策的相关性。
Pharmacoeconomics. 1992 Apr;1(4):265-81. doi: 10.2165/00019053-199201040-00004.